Publications database

This page provides answers to the questions most often asked about drug overdose deaths in Europe. Also known as drug-induced deaths, they are deaths directly attributable to the use of illicit drugs...

This miniguide is part of the Health and social responses to drug problems: a European guide . For an overview of the miniguides available, please visit the European Responses Guide 2021 page...

These accounts have been drawn up and signed off by the Accounting Officer on 30 May 2023 and approved by the Director on 31 May 2023. The opinion of the Management Board...

This page draws on the latest data available to provide an overview of the current situation and emerging drug issues affecting Europe, with a focus on the year up to the end...

Harm reduction encompasses interventions, programmes and policies that seek to reduce the health, social and economic harms of drug use to individuals, communities and societies. On this page, you can find the...

The European Drug Report 2023: Trends and Developments presents the EMCDDA’s latest analysis of the drug situation in Europe. Focusing on illicit drug use, related harms and drug supply, the report contains...

Cannabis remains by far the most commonly consumed illicit drug in Europe. On this page, you can find the latest analysis of the drug situation for cannabis in Europe, including prevalence of...

Cocaine is, after cannabis, the second most commonly used illicit drug in Europe, although prevalence levels and patterns of use differ considerably between countries. On this page, you can find the latest...

Heroin remains Europe’s most commonly used illicit opioid and is also the drug responsible for a large share of the health burden attributed to illicit drug consumption. Europe’s opioid problem, however, has...

Despite a continued decline in injecting drug use over the past decade in Europe, this behaviour is still responsible for a disproportionate level of health harms. On this page, you can find...